• Globe Newswire

Menarini nears €4.9 billion in 2025 and focuses on talent and AI as ‘giant’ players enter pharma

Globenewswire -

• Globe Newswire

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Globenewswire -

• Globe Newswire

OPEN Health Appoints Matt D’Auria as Chief Executive Officer to Drive Innovation and Growth

Globenewswire -

• Globe Newswire

Bahrain Makes History with First Successful CRISPR-Based Sickle Cell Treatment Outside the US

Globenewswire -

• Globe Newswire

London Research & Pharmaceuticals (LRP) Presents the Advancement of LRP-661, Their Lead Drug Candidate, at the Seventeenth Eilat Conference on New Antiepileptic Drugs and Devices (EILAT XVII) Conference in Madrid, Spain, 5-8 May 2024

• Globe Newswire

CARBOGEN AMCIS announces successful ANVISA audit of its facility in China